NEW YORK (GenomeWeb) – Following completion of a validation study, German prenatal genetic testing provider LifeCodexx plans to launch a new noninvasive prenatal fetal trisomy test that is based on methylation-specific quantitative PCR.

The new test, called qNIPT, will become available "as soon as possible," LifeCodexx CEO Michael Lutz told GenomeWeb. It will initially only detect fetal trisomy 21 but is expected to cover other fetal trisomies in the future.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.